Get started
Author

Ana Maria Cabal-Herrera

Observed names: AM Cabal-Herrera, Ana M Cabal-Herrera, Ana M. Cabal Herrera, Ana M. Cabal-Herrera, Ana Maria Cabal Herrera, Ana María Cabal-Herrera, Cabal-Herrera, Ana María
Observed institutions: Nationwide Children's Hospital, Massachusetts General Hospital, University of California Davis Medical Center, UC Davis Health, The Ohio State University, University of California, Davis, Universidad del Valle
ORCID: 0000-0002-4879-4896
Observed ORCID: 0000-0002-4879-4896
OpenAlex ID: A5141259516
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications
2020 · Ana Maria Cabal-Herrera, Nattaporn Tassanakijpanich, et al. · International Journal of Molecular Sciences · 119
PDF
Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments
2020 · Maria Jimena Salcedo-Arellano, Ana Maria Cabal-Herrera, et al. · Neurotherapeutics · 31
PDF
Elevated FMR1-mRNA and lowered FMRP – A double-hit mechanism for psychiatric features in men with FMR1 premutations
2020 · Andrea Schneider, Tri Indah Winarni, et al. · Translational Psychiatry · 27
PDF
Fragile X syndrome in children
2023 · David O. Acero-Garcés, Wilmar Saldarriaga, et al. · Colombia medica · 14
PDF
Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series
2020 · Maria Jimena Salcedo-Arellano, Ana Maria Cabal-Herrera, et al. · Biomedicines · 12
PDF
Fragile X Syndrome and Targeted Treatments
2020 · Nattaporn Tassanakijpanich, Ana María Cabal-Herrera, et al. · Journal of Biomedicine and Translational Research · 10
PDF
The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness
2022 · David Hessl, Hilary Rosselot, et al. · Journal of Medical Genetics · 8
PDF
A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis optica
2022 · Dylan R. Rice, Shuhei Nishiyama, et al. · Multiple Sclerosis and Related Disorders · 8
COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
2021 · Ana Maria Cabal-Herrera, Farrah J. Mateen · Journal of Neurology · 8
PDF
Fragile X associated neuropsychiatric disorders in a male without FXTAS
2020 · Ana María Cabal-Herrera, Wilmar Saldarriaga-Gil, et al. · Intractable & Rare Diseases Research · 7
PDF
Randomized Controlled Trials for Neuromyelitis Optica Spectrum Disorder
2021 · Ana M. Cabal-Herrera, Farrah J. Mateen · The Neurologist · 2
Zika Virus: Challenges and Advances on an Ongoing Threat
2026 · Diego A. Cruz-Vidal, Ana M Cabal-Herrera, et al. · Current Clinical Microbiology Reports
PDF
Unveiling the unseen: Distinguishing and dignifying the essential role of environmental services staff
2022 · Ana M. Cabal Herrera, Valencia P. Walker, et al. · Journal of Hospital Medicine
Surgimiento de los micro-RNA como biomarcadores potenciales en diversas enfermedades
2016 · Universidad del Valle, JV Forero-Forero, et al. · IATREIA
PDF
Surgimento dos micro-RNA como bio-marcadores potenciais em diversas doenças
2016 · Forero-Forero, José Vicente, González-Teshima, Laura Yuriko, et al. · IATREIA
PDF
Works count: 15
Citation count: 246
H-index: 8
I10-index: 6
Year
Topic
Type